Becton, Dickinson and Company (BDX) — Fair Value Analysis
Base-case fair value (P50): $178.54 · Current price: $183.40 · Verdict: Fairly Valued
The Verdict on BDX
Based on our Monte Carlo simulations, Becton Dickinson (BDX) is currently Fairly Valued. The stock trades at $183.40, slightly above its median fair value (P50) of $178.54, implying an -2.6% against its current price. This slight divergence indicates that BDX's market price closely aligns with its intrinsic valuation derived from thousands of forward-looking scenarios. Given its current price point relative to its statistically derived fair value, investors should interpret the present valuation as reflective of its fundamental outlook within the Healthcare sector.
How BDX stacks up against Healthcare
BDX's operational and financial health is categorized as average when compared to its peers within the broader Healthcare sector. This quality tier is a critical input into our Monte Carlo simulations, influencing the range and probability distribution of future cash flows and ultimately, the fair value. The fact that BDX's market price of $183.40 is so close to its $178.54 fair value suggests that the market is appropriately pricing in this average quality tier, neither significantly rewarding nor punishing the stock for its relative standing. The -2.6% figure reinforces this tight alignment.
What this means for investors
For investors considering BDX, the current Fairly Valued assessment, with a market price of $183.40 and a median fair value of $178.54, suggests limited immediate alpha opportunities from a pure valuation standpoint. The -2.6% indicates the market has largely absorbed existing fundamental information. Significant price movements from here would likely require new catalysts, either positive or negative, to shift the fair value distribution. FairCurve subscribers can access the full Monte Carlo distribution, including bear (P10) and bull (P90) case targets, to understand the range of potential outcomes. Sign up for FairCurve to see the full bear/bull distribution and track BDX's fair value as new fundamentals are released.
Frequently Asked Questions
Is BDX overvalued or undervalued right now?
Based on our Monte Carlo simulations, BDX is currently Fairly Valued, with its current price of $183.40 trading very close to its median fair value (P50) of $178.54.
What is the bear case and bull case for BDX?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) targets and the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate BDX's fair value?
FairCurve uses advanced Monte Carlo simulations to model BDX's future performance across thousands of forward scenarios, generating a robust probability distribution of its intrinsic fair value.
How can I track BDX's fair value as it changes?
You can add BDX to a free FairCurve watchlist to receive daily fair-value updates and instantly see its re-valuation when new earnings are released.